Financial Info
Quarterly Release
Annual Reports
Subsidiary Accounts
Q1
Q2
Q3
Q4
![Health Canada[268]](https://www.suvenpharm.com/wp-content/uploads/2022/11/Health-Canada268.png)
![ANVISA](https://www.suvenpharm.com/wp-content/uploads/2022/11/ANVISA.jpg)
![download](https://www.suvenpharm.com/wp-content/uploads/2022/11/download.jpg)
![download](https://www.suvenpharm.com/wp-content/uploads/2022/11/download.png)
![FDA](https://www.suvenpharm.com/wp-content/uploads/2022/11/FDA.jpg)
![kfda](https://www.suvenpharm.com/wp-content/uploads/2022/11/kfda.png)
![tfda](https://www.suvenpharm.com/wp-content/uploads/2022/11/tfda.png)
![OGYEIlogo_2](https://www.suvenpharm.com/wp-content/uploads/2023/06/OGYEIlogo_2.jpg)
202, A-Wing, Galaxy Towers, Plot No-1, Hyderabad Knowledge City, TSIIC, Raidurg, Serilingampally, Rangareddy District, Hyderabad-500081 Telangana, India
info@suvenpharm.com
215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala Midc, Mumbai- 400093, Maharashtra, India
CIN : L24299MH2018PLC422236
202, A-Wing, Galaxy Towers, Plot No-1, Hyderabad Knowledge City, TSIIC, Raidurg, Serilingampally, Rangareddy District, Hyderabad-500081 Telangana, INDIA.
CIN : L24299MH2018PLC422236
Registered Office:
Suven Pharmaceuticals Ltd.
215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala Midc, Mumbai- 400093, Maharashtra, India